These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1831229)

  • 1. High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides.
    Kessler RM; Ansari MS; de Paulis T; Schmidt DE; Clanton JA; Smith HE; Manning RG; Gillespie D; Ebert MH
    J Nucl Med; 1991 Aug; 32(8):1593-600. PubMed ID: 1831229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.
    de Paulis T
    Curr Pharm Des; 2003; 9(8):673-96. PubMed ID: 12570798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM; Ansari MS; Schmidt DE; de Paulis T; Clanton JA; Innis R; al-Tikriti M; Manning RG; Gillespie D
    Life Sci; 1991; 49(8):617-28. PubMed ID: 1830917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
    Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
    Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
    Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain.
    Kessler RM; Votaw JR; Schmidt DE; Ansari MS; Holdeman KP; de Paulis T; Clanton JA; Pfeffer R; Manning RG; Ebert MH
    Life Sci; 1993; 53(3):241-50. PubMed ID: 8321085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo characteristics of IBZM in rat brains: an agent for quantitative SPECT imaging of D2 dopamine receptors--a basis for semiquantitative measurement of the receptor density using equilibrium analysis].
    Toyama H; Matsumura K; Nakashima H; Ichise M; Kurami M; Nakagawa T; Maeda H; Takeuchi A; Koga S
    Kaku Igaku; 1994 Sep; 31(9):1117-20. PubMed ID: 7967197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.
    de Paulis T; Janowsky A; Kessler RM; Clanton JA; Smith HE
    J Med Chem; 1988 Oct; 31(10):2027-33. PubMed ID: 3172140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
    Neve KA; Henningsen RA; Kinzie JM; De Paulis T; Schmidt DE; Kessler RM; Janowsky A
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1108-16. PubMed ID: 2138666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.
    Joyce JN; Janowsky A; Neve KA
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1253-63. PubMed ID: 1828505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
    Kung MP; Kung HF; Billings J; Yang Y; Murphy RA; Alavi A
    J Nucl Med; 1990 May; 31(5):648-54. PubMed ID: 2140409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
    Schwarz J; Tatsch K; Vogl T; Kirsch CM; Trenkwalder C; Arnold G; Gasser T; Oertel WH
    Mov Disord; 1992; 7(1):58-61. PubMed ID: 1532631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors.
    Luedtke RR; Freeman RA; Boundy VA; Martin MW; Huang Y; Mach RH
    Synapse; 2000 Dec; 38(4):438-49. PubMed ID: 11044891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
    Vessotskie JM; Kung MP; Chumpradit S; Romaniello G; McElgin W; Frederick D; Malison RT; Kung HF
    J Nucl Med; 1995 Jul; 36(7):1282-8. PubMed ID: 7790957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors.
    Janowsky A; De Paulis T; Clanton JA; Smith HE; Ebert MH; Kessler RM
    Eur J Pharmacol; 1988 May; 150(1-2):203-5. PubMed ID: 3402540
    [No Abstract]   [Full Text] [Related]  

  • 19. Visualization of extrastriatal dopamine D2 receptors in the human brain.
    Kessler RM; Mason NS; Votaw JR; De Paulis T; Clanton JA; Ansari MS; Schmidt DE; Manning RG; Bell RL
    Eur J Pharmacol; 1992 Nov; 223(1):105-7. PubMed ID: 1478255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [125]I-spectramide: a novel benzamide displaying potent and selective effects at the D2 dopamine receptor.
    Sánchez-Roa PM; Grigoriadis DE; Wilson AA; Sharkey J; Dannals RF; Villemagne VL; Wong DF; Wagner HN; Kuhar MJ
    Life Sci; 1989; 45(19):1821-9. PubMed ID: 2531826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.